Status:
COMPLETED
Neurobehavioral Moderators of Post-traumatic Disease Trajectories
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Collaborating Sponsors:
New York University
Texas A&M University
Conditions:
PTSD
Trauma
Eligibility:
All Genders
18-65 years
Brief Summary
The research goal is to uncover the neurocognitive moderators of PTSD trajectories, by documenting clinical symptoms, cognitive functioning, and brain structure and function, one-, six- and fourteen m...
Eligibility Criteria
Inclusion
- Age 18 - 65 years
- Able to read and comprehend Hebrew
- Arrived in the ER because of one of the following: car accidents, terrorist attacks, work accidents, home accidents, burns, physical assault, large-scale disaster.
Exclusion
- Individuals with known claustrophobia
- Individuals with history of substance abuse
- Individuals with current or past psychotic or bipolar I disorder
- Individuals with chronic PTSD at the time of the current trauma
- Individuals on psychotropic medication or recreational drugs in the week that precedes the MRI
- Individuals with hearing problems
- Individuals with head trauma with coma exceeding 30 minutes
- Individuals which can't perform MRI due to safety reasons (e.g. irremovable metals in their body)
Key Trial Info
Start Date :
January 20 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 11 2020
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT03756545
Start Date
January 20 2015
End Date
March 11 2020
Last Update
March 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel